Enveric Biosciences, Inc. (ENVB)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-210.0%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | $39.91M | $43.00M | $48.59M | $36.15M |
| Cost of Revenue | — | — | — | — | — | — | $31.76M | $34.01M | $38.36M | $29.22M |
| Gross Profit | — | — | — | — | — | — | $8.15M | $8.98M | $10.24M | $6.93M |
| Operating Income | -$8.77M | -$9.63M | -$16.45M | -$27.42M | -$64.62M | -$5.62M | -$2.30M | -$7.15M | -$10.90M | -$5.38M |
| Net Income | -$8.77M | -$9.57M | -$17.29M | -$18.47M | -$48.98M | -$6.86M | -$2.41M | -$16.90M | -$9.07M | -$2.78M |
| EPS (Diluted) | $-36.24 | $-228.48 | $-121.29 | $-13.00 | $-103.69 | — | $-2.83 | $-20.47 | $-0.75 | $-0.21 |
| Total Assets | $5.10M | $3.08M | $4.30M | $19.55M | $26.72M | $4.10M | $108.8K | $29.64M | $52.20M | $39.51M |
| Total Liabilities | — | — | — | $4.00M | $4.41M | $681.2K | $1.92M | $18.88M | $32.75M | $27.84M |
| Shareholders' Equity | $4.18M | $1.59M | $1.96M | $14.67M | $22.31M | $3.42M | -$1.81M | -$65.5K | $19.45M | $11.66M |
| Cash & Equivalents | — | — | — | — | — | — | $431.4K | $1.37M | $4.88M | $1.38M |
| Operating Cash Flow | -$8.14M | -$7.73M | -$14.09M | -$17.15M | -$11.46M | -$3.89M | -$647.9K | -$2.57M | -$2.74M | -$2.70M |
| Capital Expenditures | — | — | $5.2K | $584.2K | $189.7K | — | — | — | — | — |
| Shares Outstanding | 1.06M | 56.5K | 182.6K | 2.08M | 651.9K | 10.10M | 5.31M | 1.69M | 18.16M | 13.89M |